{"id": 669181018419654658, "lang": "en", "text": "RT @nytimesbusiness: The blockbuster drug merger of Pfizer and Allergan has reignited the debate on tax overhaul. https://t.co/e6jtFzrYai h\u2026", "urls": [{"url": "https://t.co/e6jtFzrYai", "expanded_url": "http://nyti.ms/1Xo1bUV"}], "user": {"id": 250188760}, "id_str": "669181018419654658", "source": "<a href=\"https://about.twitter.com/products/tweetdeck\" rel=\"nofollow\">TweetDeck</a>", "deleted": false, "hashtags": [], "retrieved": "2018-02-02--11-00-16", "created_at": "Tue Nov 24 15:49:22 +0000 2015", "retweet_count": 26, "user_mentions": [{"id": 1754641, "name": "NYT Business", "screen_name": "nytimesbusiness"}], "legacy_imported": true, "retweeted_status": {"id": 669139686997102592, "lang": "en", "text": "The blockbuster drug merger of Pfizer and Allergan has reignited the debate on tax overhaul. https://t.co/e6jtFzrYai https://t.co/j0UpVh8kU8", "urls": [{"url": "https://t.co/e6jtFzrYai", "expanded_url": "http://nyti.ms/1Xo1bUV"}], "user": {"id": 1754641}, "media": [{"id": 669139685336223744, "url": "https://t.co/j0UpVh8kU8", "type": "photo", "sizes": {"large": {"h": 560, "w": 1000, "resize": "fit"}, "small": {"h": 381, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 560, "w": 1000, "resize": "fit"}}, "media_url": "http://pbs.twimg.com/media/CUlC_6GVEAALURx.png", "display_url": "pic.twitter.com/j0UpVh8kU8", "expanded_url": "https://twitter.com/nytimesbusiness/status/669139686997102592/photo/1", "media_url_https": "https://pbs.twimg.com/media/CUlC_6GVEAALURx.png"}], "id_str": "669139686997102592", "source": "<a href=\"http://www.socialflow.com\" rel=\"nofollow\">SocialFlow</a>", "hashtags": [], "created_at": "Tue Nov 24 13:05:08 +0000 2015", "retweet_count": 26, "user_mentions": [], "favorite_count": 18}}